Ortho Clinical Diagnostics Holdings PLC
NASDAQ:OCDX
Intrinsic Value
Ortho Clinical Diagnostics Holdings Plc provides vitro diagnostics services. [ Read More ]
There is not enough data to reliably calculate the intrinsic value of OCDX.
Fundamental Analysis
Our AI Assistant is coming soon! Stay tuned and thank you for your interest!
Provide an overview
of Ortho Clinical Diagnostics Holdings PLC's business.
What risks and challenges
does Ortho Clinical Diagnostics Holdings PLC face in the near future?
Summarize the latest earnings report
of Ortho Clinical Diagnostics Holdings PLC.
Provide P/E
for Ortho Clinical Diagnostics Holdings PLC and its competitors.
Balance Sheet Decomposition
Ortho Clinical Diagnostics Holdings PLC
Current Assets | 989.6m |
Cash & Short-Term Investments | 281.1m |
Receivables | 293.2m |
Other Current Assets | 415.3m |
Non-Current Assets | 2.3B |
PP&E | 784.2m |
Intangibles | 840.7m |
Other Non-Current Assets | 701.9m |
Current Liabilities | 522.7m |
Accounts Payable | 169.5m |
Accrued Liabilities | 239.7m |
Other Current Liabilities | 113.5m |
Non-Current Liabilities | 2.4B |
Long-Term Debt | 2.2B |
Other Non-Current Liabilities | 173.3m |
Earnings Waterfall
Ortho Clinical Diagnostics Holdings PLC
Revenue
|
2B
USD
|
Cost of Revenue
|
-1B
USD
|
Gross Profit
|
1B
USD
|
Operating Expenses
|
-864.5m
USD
|
Operating Income
|
163.5m
USD
|
Other Expenses
|
-163.9m
USD
|
Net Income
|
-400k
USD
|
Free Cash Flow Analysis
Ortho Clinical Diagnostics Holdings PLC
What is Free Cash Flow?
OCDX Profitability Score
Profitability Due Diligence
Ortho Clinical Diagnostics Holdings PLC's profitability score is 49/100. The higher the profitability score, the more profitable the company is.
Score
Ortho Clinical Diagnostics Holdings PLC's profitability score is 49/100. The higher the profitability score, the more profitable the company is.
OCDX Solvency Score
Solvency Due Diligence
Ortho Clinical Diagnostics Holdings PLC's solvency score is 23/100. The higher the solvency score, the more solvent the company is.
Score
Ortho Clinical Diagnostics Holdings PLC's solvency score is 23/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
OCDX Price Targets Summary
Ortho Clinical Diagnostics Holdings PLC
Ownership
OCDX Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Shareholder Return
OCDX Price
Ortho Clinical Diagnostics Holdings PLC
Average Annual Return |
N/A
|
Standard Deviation of Annual Returns |
N/A
|
Max Drawdown | -28% |
Market Capitalization | 4.2B USD |
Shares Outstanding | 237 735 008 |
Percentage of Shares Shorted | 5.91% |
OCDX News
Last Important Events
Ortho Clinical Diagnostics Holdings PLC
Significant happenings or occurrences that are of interest to investors. These could be company-specific developments or market-wide shifts.
Sentiment Analysis
Ortho Clinical Diagnostics Holdings PLC
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
Ortho Clinical Diagnostics Holdings Plc provides vitro diagnostics services. The company is headquartered in Raritan, New Jersey and currently employs 4,800 full-time employees. The company went IPO on 2021-01-28. The firm provides laboratory testing and blood-typing solutions to the clinical laboratory and transfusion medicine communities. The firm provides customized solutions for clinical outcomes, lab performance and staffing challenges. The firm operates through two lines of business such as Clinical Laboratories and Transfusion Medicine. Its Clinical Laboratories business focuses on clinical chemistry and immunoassay instruments and tests to detect and monitor disease progression across therapeutic areas. The Transfusion Medicine business is focused on immunohematology instruments and tests used for blood typing to ensure patient-donor compatibility in blood transfusions. Its Donor Screening business is focused on instruments and tests used for blood and plasma screening for infectious diseases for customers, which include some of the donor testing institutions.